Complete heart block: Determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy

被引:78
|
作者
Chang, SM [1 ]
Nagueh, SF [1 ]
Spencer, WH [1 ]
Lakkis, NM [1 ]
机构
[1] Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA
关键词
D O I
10.1016/S0735-1097(03)00623-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The purpose of this paper is to examine the incidence and determinants of permanent complete heart block (CHB) after nonsurgical septal reduction therapy (NSRT), and to evaluate the clinical impact of permanent pacemaker (PPM) placement. BACKGROUND Nonsurgical septal reduction therapy with ethanol improves the clinical and hemodynamic parameters in patients with symptomatic hypertrophic obstructive cardiomyopathy. Complete heart block is a common complication after NSRT. METHODS The database of 261 consecutive patients who underwent NSRT at Baylor College of Medicine was reviewed. Clinical variables that were considered as possible determinants for CHB after NSRT were: age, gender, New York Heart Association (NYHA) functional class, left ventricular outflow tract (LVOT) gradient at rest or with provocation, septal thickness, and baseline exercise duration. For electrocardiographic (ECG) variables, the presence of first-degree atrioventricular (AV) block, bifascicular block, left bundle branch block, atrial fibrillation, and left ventricular hypertrophy were analyzed. In addition, the volume of ethanol injected, the method of administration of ethanol (i.e., bolus vs. slow injection [over 30 to 60 s]), number of septal arteries occluded, use of myocardial echocardiography, and infarct size as determined by peak creatine kinase level. RESULTS Of 261 consecutive patients, 37 had PPM or automatic implantable cardiac defibrillator placed before NSRT. Of the remaining 224 patients, 31 (14%) developed CHB after the procedure. Multivariate logistic regression analysis showed that female gender (odds ratio [OR] 4.3; p = 0.02), bolus injection of ethanol (OR 51; p = 0.004), injecting more than one septal artery (OR 4.6; p = 0.016), the presence of left bundle branch block (OR 39; p = 0.002), and first-degree AV block (OR 14; p = 0.001) on the baseline ECG are independent predictors of CHB after NSRT. Patients requiring PPM placement had a similar improvement in their NYHA functional class, septal thickness reduction, LVOT gradient reduction, and improvement of exercise capacity when compared with patients who did not require pacing. CONCLUSIONS Multiple demographic, electrocardiographic, and technical factors seem to increase the risk of CHB after NSRT. Patients with CHB after NSRT derive similar clinical and hemodynamic benefit to patients who did not require permanent pacing. (C) 2003 by the American College of Cardiology Foundation.
引用
收藏
页码:296 / 300
页数:5
相关论文
共 50 条
  • [41] Delayed occurrence of complete heart block without warning after alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    Kern, MJ
    Holmes, DG
    Simpson, C
    Bitar, SR
    Rajjoub, H
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2002, 56 (04) : 503 - 507
  • [42] Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
    Nagueh, SF
    Lakkis, NM
    Middleton, KJ
    Killip, D
    Zoghbi, WA
    Quiñones, MA
    Spencer, WH
    CIRCULATION, 1999, 99 (03) : 344 - 347
  • [43] Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy: Volume Still Matters for Septal Myectomy
    See, Vincent Y. Y.
    Wang, Libin
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (10):
  • [44] Pathological Features Correlate With Clinical Manifestations in Patients With Obstructive Hypertrophic Cardiomyopathy Undergoing Septal Myectomy
    Cui, Hao
    Carvalho, Juliano Lentz
    Nishimura, Rick A.
    Geske, Jeffrey B.
    Dearani, Joseph A.
    Lahr, Brian
    Ommen, Steve R.
    Maleszewski, Joseph J.
    Schaff, Hartzell V.
    CIRCULATION, 2019, 140
  • [45] Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy
    Altibi, Ahmed M.
    Ghanem, Fares
    Zhao, Yuanzi
    Elman, Miriam
    Cigarroa, Joaquin
    Nazer, Babak
    Song, Howard K.
    Masri, Ahmad
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (10):
  • [46] Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy
    Flores-Ramirez, R
    Lakkis, NM
    Middleton, KJ
    Killip, D
    Spencer, WH
    Nagueh, SF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (01) : 208 - 214
  • [47] A Simple and Inexpensive Option for Nonsurgical Septal Reduction in Hypertrophic Obstructive Cardiomyopathy Embolization of the Septal Artery With Subcutaneous Fat Tissue
    Cagdas, Metin
    Karakoyun, Suleyman
    Yesin, Mahmut
    Rencuzogullari, Ibrahim
    Artac, Inanc
    Cinar, Tufan
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (11) : E101 - E102
  • [48] Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy
    Boekstegers, P
    Steinbigler, P
    Molnar, A
    Schwaiblmair, M
    Becker, A
    Knez, A
    Haberl, R
    Steinbeck, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (03) : 846 - 853
  • [50] Contemporary Septal Reduction Therapy in Drug-Refractory Hypertrophic Obstructive Cardiomyopathy
    Maekawa, Yuichiro
    Akita, Keitaro
    Takanashi, Shuichiro
    CIRCULATION JOURNAL, 2018, 82 (08) : 1977 - 1984